The Uromigos

The Uromigos

By The Uromigos
Broadcasting the latest developments in GU cancer
Where to listen
Apple Podcasts Logo
Breaker Logo
Google Podcasts Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Episode 26: Joaquim Bellmunt and Muscle Invasive Bladder Cancer prior to ASCO20 Data
Joaquim Bellmunt talks about management of muscle invasive bladder cancer prior to the Atezolizumab adjuvant data at ASCO20. 
22:23
May 19, 2020
Episode 25: Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial
Dr. Tian Zhang discusses first line treatment for renal cancer and the PDIGREE Trial.
14:47
May 19, 2020
Episode 24: A Study of COVID-19 in Lung Cancer Shows High Mortality
Marina Garassino and Leora Horn discuss their AACR study of COVID-19 in lung cancer.
19:51
April 28, 2020
Episode 23: Atezolizumab and Enzalutamide versus Enzalutamide Prostate Cancer
Chris Sweeney explains why the trial was negative and answers some of the questions.
22:35
April 28, 2020
Episode 22: COVID-19 and Cardiovascular Disease
Kaushik Amancherla and Javid Moslehi discuss the link of COVID-19 and cardiovascular disease. Professor Tom Powles and Dr. Brian Rini struggle to keep up.
18:28
April 22, 2020
Episode 21: Treating cancer patients over the next year in the era of COVID-19
The Uromigos struggle to describe what cancer care looks like in three months’ time during the COVID-19 pandemic.
12:33
April 15, 2020
Episode 20: Treating GU Cancer Patients with acute COVID-19 Infection
The Uromigos can’t agree on how to approach COVID-infected GU cancer patients who need systematic treatment.
13:07
April 15, 2020
Episode 19: Professor Monty Pal discusses the treatment of non-clear cell renal cancer
Professor Monty Pal discusses non-clear cell renal cancer while Dr. Brian Rini gets irritated by background interruptions. 
18:17
April 15, 2020
Episode 18: COVID-19: Addressing Renal Cancer Patients’ Concerns
Dena Battle presents a 500-patient survey on issues around COVID-19. Professor Tom Powles and Dr. Brian Rini attempt to address the issues raised.
24:46
April 6, 2020
Episode 17: Dr. Toni Choueiri discusses cancer trials and meetings during COVID-19
Professor Tom Powles, Dr. Brian Rini and Dr. Toni Choueiri discuss the evolving landscape in Boston, and meetings such as ASCO and ESMO in 2020.
21:33
April 2, 2020
Episode 16: Treatments and Trials for COVID-19
Professor Nick Mark discusses the latest data on drug treatments and trials for COVID-19.
25:31
March 31, 2020
Episode 15: COVID-19 and Bladder Cancer Surgery
The Uromigos discuss the practicalities in surgery for bladder cancer in the era of COVID-19 with Betsy Plimack (Fox Chase Cancer Center, Philadelphia)
14:52
March 28, 2020
Episode 14: A Discussion about Tocilizumab and COVID-19 with Dr. Nick Mark from Seattle
Dr. Brian Rini and Professor Tom Powles discuss the data and ongoing studies with the IL-6 antibody tocilizumab.
15:04
March 24, 2020
Episode 13: COVID-19 and Hydroxychloroquinine Existing Data and Ongoing Trials
Dr. David Boulware discusses existing data and ongoing prophylaxis studies.
18:44
March 23, 2020
Episode 12: COVID-19 in Cancer Patients - The Seattle Experience
A discussion with doctors from the Fred Hutchinson Cancer Center in Seattle about COVID-19.
26:19
March 20, 2020
Episode 11: COVID-19 and Immune Checkpoint Inhibitors for the Treatment of Cancer
Chuck Drake and Doug Johnson discuss possible risk benefits of immune checkpoint inhibitors during the COVID-19 pandemic. 
17:43
March 16, 2020
Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective
Dena Battle (President, KCCure) asks key patient-focused questions about kidney cancer management during the COVID-19 pandemic. 
27:09
March 16, 2020
Episode 9: COVID-19 and Cancer: An International Perspective
Five members of the groups from Europe and North America discuss the current situation for cancer patients. 
21:58
March 16, 2020
Episode 8: COVID-19 and Cancer Patients
Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen. 
21:54
March 13, 2020
Episode 7: The First Uromigos Prostate Cancer Podcast
Silke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer. 
25:32
February 27, 2020
Episode 6: Urothelial Cancer Highlights from ASCO GU 2020
In this episode, Professor Tom Powles and Dr. Brian Rini talk to Dr. Kala Sridhar about key developments in urothelial cancer presented at ASCO GU 2020. 
20:08
February 26, 2020
Episode 5: Renal Highlights from ASCO GU 2020
Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco. 
10:14
February 24, 2020
Episode 4: Treatment Choices in Front Line Advanced Renal Cancer
Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment options
26:39
February 11, 2020
Episode 3: Pembrolizumab in Non-Muscle Invasive Bladder Cancer
Guests Dr. Arjun Balar and Professor Seth Lerner give an overview of the recent FDA approval of pembrolizumab in this indication to Professor Tom Powles and Dr. Brian Rini.
33:02
February 11, 2020
Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer
Matthew Galski and Petros Grivas engage in a discussion with Professor Tom Powles and Dr. Brian Rini about IMVIGOR130.
30:18
February 11, 2020
Episode 1: Introduction to Uromigos Podcasts
Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them
03:20
February 11, 2020